Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration by Maheshwari, Gargi et al.
 
JCB
 

 
 The Rockefeller University Press, 0021-9525/2001/12/1123/6 $5.00
The Journal of Cell Biology, Volume 155, Number 7, December 24, 2001 1123–1128
http://www.jcb.org/cgi/doi/10.1083/jcb.200109060 1123
 
Report
 
Autocrine epidermal growth factor signaling 
stimulates directionally persistent mammary 
epithelial cell migration
 
Gargi Maheshwari,
 
1
 
 H. Steven Wiley,
 
4
 
 and Douglas A. Lauffenburger
 
1,2,3
 
1
 
Department of Chemical Engineering, 
 
2
 
Division of Bioengineering and Environmental Health, and 
 
3
 
Center for Cancer 
Research, Massachusetts Institute of Technology, Cambridge, MA 02139
 
4
 
Fundamental Sciences Division, Paciﬁc Northwest National Laboratory, Richland, WA 99352
 
ell responses to soluble regulatory factors may be
strongly inﬂuenced by the mode of presentation of
the factor, as in matrix-bound versus diffusible
modes. The possibly diverse effect of presenting a growth
factor in autocrine as opposed to exogenous (or paracrine)
mode is an especially important issue in cell biology. We
 
demonstrate here that migration behavior of human
mammary epithelial cells in response to stimulation by
epidermal growth factor (EGF) is qualitatively different for
EGF presented in exogenous (paracrine), autocrine, and
intracrine modes. When EGF is added as an exogenous
factor to the medium of cells that express EGF receptor
(EGFR) but not EGF, cell migration speed increases while di-
rectional persistence decreases. When these EGFR-expressing
cells are made to also express via retroviral transfection
EGF in protease-cleaveable transmembrane form on the
plasma membrane, migration speed similarly increases,
C
 
but directional persistence increases as well. Addition of
exogenous EGF to these cells abrogates their enhanced
directional persistence, reducing their directionality to a
level similar to wild-type cells. If the EGFR-expressing cells
are instead transduced with a gene encoding EGF in a soluble
form, migration speed and directional persistence were
unaffected. Thus, autocrine presentation of EGF at the
plasma membrane in a protease-cleavable form provides
these cells with an enhanced ability to migrate persistently
in a given direction, consistent with their increased capability
for organizing into gland-like structures. In contrast, an
exogenous/paracrine mode of EGF presentation generates
a “scattering” response by the cells. These ﬁndings emphasize
the functional importance of spatial restriction of EGFR
signaling, and suggest critical implications for growth
factor–based therapeutic treatments.
 
Introduction
 
Autocrine receptor/ligand signaling loops were first identi-
fied in tumor cells, where it was found that transformation
of cells resulted in overexpression of certain growth factors
leading to unregulated proliferation of the tumor cells
(Sporn and Todaro, 1980). However, in the ensuing decades
autocrine signaling has been found to operate in numerous
physiological situations (Sporn and Roberts, 1992), includ-
ing wound healing (Tokumaru et al., 2000), angiogenesis
(Seghezzi et al., 1998), and tissue organization during devel-
opment (Wasserman and Freeman, 1998) and reproductive
cycles (Xie et al., 1997). Although it is becoming evident
that autocrine loops play crucial roles in regulation of cell
function within tissue contexts, it is unclear whether their
effects on cell responses are different from the effects of the
same ligand presented in exogenous or paracrine manner.
Hypotheses that the effects of autocrine presentation may be
significantly disparate from those of exogenous/paracrine
presentation can be motivated, at least, by analogous
findings that cell responses to some ligands are different
depending on whether the ligands are presented in soluble
versus substratum-bound form (Massague and Pandiella,
1993). An underlying mechanistic foundation for this con-
cept is provided by the recently growing evidence that diver-
sity of pathway activation from a given receptor is dependent
on compartmental location of the signaling ligand–receptor
complexes (Carraway and Carraway, 1995; DiFiore and
Gill, 1999; Ceresa and Schmid, 2000).
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A particular and important case in point is the organiza-
tion of mammary epithelial cells (MECs)* into structured
tissues regulated by EGF receptor (EGFR)-mediated auto-
crine signaling by various epidermal growth factor (EGF)
family ligands (Wiley et al., 1998). EGF family ligands, in-
cluding EGF itself, transforming EGF-like growth factor 
 
 
 
(TGF
 
 
 
), amphiregulin (AR), and heparin-binding growth
factor (HB-EGF), are normally synthesized as transmem-
brane precursors which are then proteolytically cleaved and
processed to release the mature peptide ligand (Massague
and Pandiella, 1993). The various EGF family ligands show
diverse levels of expression among cell types and tissue con-
text, and the issue of whether each might serve distinct phys-
iological roles is under vigorous investigation (Cook et al.,
1995; Dempsey et al., 1997; Sweeney and Carraway, 2000).
To test the hypothesis that autocrine presentation of EGF
family ligands provides for a distinct manner of cell regula-
tion, we have generated an experimental cell system in which
the presentation mode of EGF in a MEC line can be altered.
Wiley et al. (1998) used retroviral transfection to individu-
ally express each of two forms of EGF ligands in the EGFR-
expressing human MEC (HMEC) line (Stampfer and Yas-
wen, 1993) (Fig. 1). One is the mature EGF 53 amino acid
peptide retaining its cytoplasmic and transmembrane do-
main (EGF-Ct); this version is protealytically cleaved at the
cell plasma membrane, diffuses into the extracellular envi-
ronment and is recaptured by cell-surface receptors, thus op-
erating in classical autocrine mode. The second is simply the
mature EGF 53 amino acid peptide containing a signal se-
quence (sEGF). This version is generated in soluble form in
the lumen of the protein synthesis pathway where it can
bind newly synthesized (and perhaps recycling) intracellular
EGFR, thus operating in a presumably pathological intra-
crine mode. The parental HMEC cells (subtype 184A1) pro-
duce low levels of endogenous EGFR ligands and thus re-
quire exogenous EGF for optimum growth in culture. This
allows them to be used to compare autocrine and intracrine
presentation modes of EGF with that of typical paracrine
mode, where the ligand is provided exogenously in the cell
culture medium.
The disparate effects of these three modes of EGF presen-
tation on HMEC organization in vitro were striking (Wiley
et al., 1998). Presentation in the intracrine (sEGF) mode re-
sulted in a signaling loop that stimulated cell proliferation,
but in a structurally disorganized fashion. This loop was un-
interruptable, as a monoclonal antibody that blocks EGF
binding to EGFR was unable to inhibit the proliferation re-
sponse. In contrast, presentation in the autocrine (EGF-Ct)
mode stimulated HMEC to not only proliferate but also to
migrate into organized units resembling gland structures
with lobular and ductal aspects. Both the proliferation and
organizational responses of the cells to EGF-Ct were inhib-
ited by the anti-EGFR blocking antibody. Moreover, and
perhaps even most surprisingly, addition of exogenous EGF
inhibited the ability of the EGF-Ct–expressing cells to orga-
nize. These findings indicate that autocrine presentation of
EGF provides a migration-related signal involved in struc-
tural organization that is not provided by either intracrine or
exogenous/paracrine presentation.
Thus, we were motivated for this present study to directly
test whether autocrine presentation of EGF stimulates a mi-
gration behavioral response in HMEC qualitatively different
from that stimulated by intracrine and exogenous/paracrine
presentation of the same ligand. Indeed, we find that auto-
crine (EGF-Ct) presentation not only stimulates rapid
HMEC migration, but also increases directional persistence.
In contrast, intracrine (sEGF) and exogenous/paracrine
EGF stimulates migration behavior characterized by low di-
rectional persistence, similar to the “scattering” behavior dis-
played by a variety of different cell types given exogenous
growth factors (Warn, 1994; Stella and Comoglio, 1999).
Significantly, the highly persistent migration of the HMEC-
expressing EGF-Ct is lost when the autocrine EGF–EGFR
signaling is inhibited by addition of the anti-EGFR–block-
ing antibody or is supplemented by addition of exogenous
EGF. This suggests that autocrine presentation of EGF
yields a spatial localization of EGF–EGFR-signaling com-
plexes that drive the persistent locomotion behavior. This
may be part of a general mechanism involved in tissue orga-
nization and remodeling.
 
Results and discussion
 
MEC migration speed is increased by signaling from 
cell surface EGF–EGFR complexes
 
Wild-type (WT) HMEC as well as cells expressing either
sEGF or EGF-Ct were used in these studies. The structure
of the artificial sEGF and EGF-Ct genes are shown in Fig. 1.
Migration speeds of HMEC for the three different EGF pre-
sentation modes were quantified using time-lapse video mi-
croscopy of individual cells (Fig. 2). In the absence of ex-
ogenous EGF, WT HMEC exhibited a baseline mean
migration speed of 
 
 
 
50 
 
 
 
m/h. EGF-Ct–expressing cells
(autocrine presentation) exhibited substantially greater mean
speed at 
 
 
 
120 
 
 
 
m/h, whereas sEGF-expressing cells (intra-
crine presentation) showed only a small increase in mean
speed to roughly 65 
 
 
 
m/h. Addition of 2 nM exogenous
EGF increased the mean migration speeds of both WT and
sEGF-expressing cells to 90 
 
 
 
m/h, whereas the mean speeds
of EGF-Ct–expressing cells remained at 120 
 
 
 
m/h. The dif-
ferences among mean speeds of the three cell types in the
presence of 2 nM exogenous EGF are not statistically signif-
icant. Addition of 225 mAb, which blocks the binding of ex-
tracellular, but not intracellular EGF to its receptor (Wiley
et al., 1998), decreased the mean migration speed of each of
the cell types to the range of 25–35 
 
 
 
m/h. The reduction
from the original WT and sEGF cell baselines of 50–65
 
 
 
m/h is likely due to blocking of the low levels of endoge-
nous EGF family autocrine ligands in these cells (Wiley et
al., 1998). Together, these findings indicate that the migra-
tion speed of the HMEC is essentially governed by signaling
from cell surface EGF–EGFR complexes; this is consistent
with recent evidence that key pathways of EGFR-mediated
induction of enhanced cell migration reside at the plasma
membrane (Haugh et al., 1999; Glading et al., 2001). Sig-
naling by EGF–EGFR complexes at the cell surface in EGF-
Ct–expressing HMEC is relatively unaffected by additional
 
*Abbreviations used in this paper: EGFR, EGF receptor; HMEC, human
MEC; MEC, mammary epithelial cell; WT, wild-type. 
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exogenous EGF. In contrast, WT and sEGF-expressing cells
migrate at maximal speeds only when signaling by surface
EGF–EGFR complexes is increased by addition of exoge-
nous EGF.
 
Directional persistence of MEC migration is enhanced 
by autocrine EGF but reduced by exogenous EGF
 
In addition to effects on cell migration speed, EGF can
strongly affect persistence of directionality (Ware et al.,
1998). Such effects can be visualized qualitatively by repro-
ducing sample cell movement paths on windrose plots (see
Fig. 3). Fig. 3 A shows that EGF-Ct–expressing cells appear
to travel in significantly more persistent paths in comparison
to their paths in the presence of exogenous added EGF in
Fig. 3 B. However, the mean speed of migration for the cells
under these two conditions are not significantly different
(Fig. 2).
To quantify the directional persistence property of cell mi-
gration, a parameter known as persistence time can be deter-
mined from the cell paths via the same sort of mathematical
analysis by which the mean speed is obtained (Dunn and
Brown, 1987). This parameter essentially represents the mean
period of time over which a cell continues to move in a particu-
lar direction before changing direction by 
 
 
 
60 degrees. In ac-
cordance with the qualitative observations illustrated in Fig. 3,
there is a striking quantitative effect of the various EGF presen-
tation modes on HMEC directional persistence (Fig. 4). In the
absence of exogenous EGF, EGF-Ct–expressing autocrine cells
show a dramatically greater persistence time, 
 
 
 
50 min, com-
Figure 1. Cell types used in this study. WT HMECs express EGFR 
endogenously, but lack the expression of EGF. EGF-Ct cells express 
the EGF-Ct construct. EGF-Ct lacks the NH2-terminal extracellular 
domain of the human EGF precursor. The sEGF construct is simply 
the 53 amino acid long mature EGF without the NH2-terminal, 
COOH-terminal, or the transmembrane domain of EGF precursor; 
it binds to the EGFR during receptor transport to the cell surface 
(Wiley et al., 1998).
Figure 2. Effect of ligand presentation on cell speed. Filled, 
hatched, and blank bars represent the cell speeds of EGF-Ct–
expressing cells, sEGF-expressing cells, and WT HMECs, respectively. 
Cell speeds of the three cell types were monitored in the absence of 
exogenous EGF, in the presence of 2 nM exogenously added EGF, 
and in the presence of 10  g/ml 225 mAb EGFR-blocking antibody. 
Errors represent   SEM. Numbers above the bars are the number of 
individual cell tracks used in the analysis.
Figure 3. Effect of ligand presentation on cell tracks of EGF-Ct 
expressing cells. (A) Typical cell paths of cells expressing EGF-Ct 
in the absence of exogenously added EGF. Paths are of cells 
tracked over a period of 4–5 h and are replotted such that all 
paths start from the origin. (B) Cell paths of EGF-Ct–expressing 
cells in the presence of 2 nM exogenously added EGF. Cells 
shown in A and B have the same average cell speed, but have 
significantly different patterns of motion. 
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pared with those for WT and sEGF-expressing HMECs of
 
 
 
10 and 20 min, respectively. Addition of exogenous EGF ab-
rogated the highly directional motion of the EGF-Ct cells, re-
ducing their mean persistence time to 
 
 
 
15 min; persistence
time of the WT and sEGF-expressing cells remained at this low
level in the presence of the exogenous EGF. Blocking of cell-
surface binding of EGF to EGFR using 225 mAb also resulted
in reduced persistence time for the EGF-Ct cells with no effect
on the WT and sEGF-expressing cells.
The net effect of EGFR-mediated induction of cell migra-
tion by the three modes of EGF presentation can be viewed
in terms of a quantity reflecting the cell path behavior illus-
trated in the windrose plots of Fig. 3: the product of migra-
tion speed and persistence time is the “mean path length,”
plotted in Fig. 5. It is clear that EGF presented in autocrine
manner provides HMEC with an ability to migrate for
many cell lengths before altering their direction signifi-
cantly, whereas presentation of EGF in intracrine or para-
crine manner yields nondirected migration behavior which
should result in cell scattering.
These findings indicate that directional persistence of cell
migration is generated by EGF–EGFR signaling only under
conditions of the ligand being released at the cell surface for
subsequent recapture by plasma membrane receptors. The
same quality of EGFR-mediated signals are apparently not
generated by exogenous (or paracrine) ligand diffusing form
the bulk medium to bind at the cell surface or by ligand
binding intracellularly along the protein export pathway.
 
EGF presented in autocrine manner is restricted to the 
releasing cell
 
The above data suggests that spatial restriction in EGFR-
mediated signaling is an important aspect of its role in cell
migration. However, this implies that released EGF is re-
stricted to the producing cell and does not affect all the cells
in a population. To verify that the EGF-Ct autocrine loop
indeed operates locally, we made visual observations of indi-
vidual HMEC in mixed populations of EGF-Ct–expressing
and WT cells. WT HMEC were labeled green and the EGF-
Ct–expressing cells were labeled red using fluorescent vital
dyes. Their paths were then tracked over a period of 4 h. As
can be seen in the example photograph of Fig. 6, EGF-Ct–
expressing cells exhibited strong locomotion behavior while
WT cells, even those next to EGF-Ct-expressing cells, did
not move significantly from their original locations. How-
ever, when exogenous EGF was added to the media, migra-
tion of WT HMEC was stimulated (in accord with data
shown in Fig. 2), confirming that their motility apparatus
was functional. The observation that autocrine EGF-stimu-
lated migration of the EGF-Ct–expressing cells but not of
neighboring WT cells supports the notion that the EGF au-
tocrine loop is operating in spatially restricted, or “local,”
fashion. This is consistent with the predictions of a recent
theoretical study that concluded that for typical values dis-
played by the EGFR autocrine system, a major portion of re-
leased autocrine ligand should be captured within a micron
of the release point (Shvartsman et al., 2001).
 
Conclusions and speculation concerning operation of 
EGFR-mediated autocrine signaling loops
 
Together, the results of this study support the hypothesis
that autocrine presentation of EGF stimulates a migratory
cell behavioral response different from that stimulated by
other modes of presentation of the same ligand. Only auto-
crine presentation yields a highly persistent cell locomotion
response, whereas intracrine and exogenous/paracrine pre-
sentation produces a nondirectional locomotion response.
A possible mechanism underlying this directional regula-
tion might be an asymmetry in the number of EGF–EGFR
complexes across the cell, enhancing the probability that cell
locomotion will continue in the direction of that asymme-
try. This concept is consistent with earlier experimental and
Figure 4. Effect of ligand presentation on persistence time. The 
cell tracks were analyzed using a persistence random walk model to 
obtain the value of persistence time. Filled, hatched, and blank bars 
represent the cell speeds of EGF-Ct–expressing cells, sEGF-expressing 
cells, and WT HMECs, respectively. Persistence times of the three 
cell types were calculated in the absence of exogenous EGF, in the 
presence of 2 nM exogenously added EGF, and in the presence of 
10  g/ml 225 mAb EGFR-blocking antibody. Errors represent   
SEM. Numbers above the bars are the number of individual cell 
tracks used in the analysis.
Figure 5. Effect of ligand presentation on cell path length. Path 
length is the product of cell speed and persistence under a given set 
of conditions. Filled, hatched, and blank bars represent the cell 
speeds of EGF-Ct–expressing cells, sEGF-expressing cells, and WT 
HMEC respectively. Path lengths were calculated in the presence 
and absence of exogenously added EGF. 
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theoretical studies of neutrophil chemokinetic and chemo-
tactic responses (Tranquillo et al., 1988), and may provide a
means for more accurate sensing of environmental gradient
cues, whether from soluble or matrix factors. One conceiv-
able mechanism for this localized asymmetry could be a spa-
tially restricted proteolytic cleavage of transmembrane EGF
at particular locations on the plasma membrane stimulated
by local activation of EGFR. Such a positive feedback mech-
anism is consistent with previous studies showing that
EGFR ligands can stimulate their own proteolytic release
(Baselga et al., 1996). In such a situation, addition of exoge-
nous EGF would abolish the signaling asymmetry, resulting
in the reduction of directional persistence as we have ob-
served here. sEGF-expressing cells, on the other hand, would
not have the ability to generate spatially restricted EGF–
EGFR-signaling complexes because sEGF is constitutively
active.
Our findings are also consistent with previous reports of
divergence between EGFR-mediated motogenic and mi-
togenic signaling pathways at a cellular compartment level
(Chen et al., 1994, 1996; Haugh et al., 1999), by which
proliferation can be stimulated equally well by intracel-
lular and cell-surface EGF–EGFR-signaling complexes,
whereas a migratory response requires signaling at the cell
surface. Previously, we had shown that 225 mAb does not
block proliferation of cells expressing sEGF (Wiley et al.,
1998). More recently, we have shown that most of acti-
vated EGFR-signaling complexes in HMEC are located in
an intracellular compartment which would be poorly ac-
cessible to exogenous 225 mAb (Burke et al., 2001).
Thus, our observation that 225 mAb is able to block the
migration of sEGF expressers supports the idea that cell-
surface EGF–EGFR complexes rather than intracellular
complexes are principally involved in motility regulation
of these cells. This is also consistent with of the observed
differences in the ability of cell surface and internalized
EGF–EGFR complexes to stimulate PIP
 
2
 
 hydrolysis via
PLC-
 
 
 
1, which is known to be involved in EGF-stimu-
lated motility (Chen et al., 1994; Haugh et al., 1999). To-
gether, these results strongly suggest a role for compart-
mentalization of signaling molecules involved in cell
migration and provide a mechanistic basis for the ob-
served differences in the motility response of HMEC to
autocrine versus intracrine EGF.
Finally, implications for potential therapeutic approaches
to augmenting growth factor stimulation of cell function
should be noted. If the physiological mode of growth factor
presentation is autocrine, then provision of putatively thera-
peutic growth factor in exogenous or paracrine manner may
well be counter-productive, as it would stimulate a cell re-
sponse quite different from that generated by the normal au-
tocrine presentation. In such a case, a gene-based delivery of
the growth factor, targeted to the specific receptor-express-
ing cell type, would be the only feasible way to generate the
desired physiological cell function.
 
Materials and methods
 
Cell lines and cell culture
 
HMEC type 184A1 were obtained from M. Stampfer (Stampfer and Yas-
wen, 1993; Stampfer et al., 1993). The construction and characterization
of sEGF and EGF-Ct has been described previously (Wiley et al., 1998).
Briefly, the sEGF and EGF-Ct constructs were packaged using the MFG ret-
roviral vector and transfected into wild-type HMECs. For these studies,
sEGF clone #1 and EGF-Ct clone #2 were used. These cells release 1.2 and
1.7 ng EGF per 10
 
6
 
 cells/h, respectively, into the extracellular medium.
The cells were cultured in DFCI-1 media as described previously (Band
and Sager, 1989). Monoclonal antibody 225 mAb against the EGFR was
purified from hybridoma supernatants as described previously (Wiley et
al., 1998).
 
Migration assay
 
Cell migration speed was measured using time-lapse video microscopy of
single cells. 30,000 cells were plated onto 35-mm dishes in 2.5 ml serum-
free medium. 20 h postseeding, the medium was changed to 2.5 ml assay
medium with or without 2 nM EGF and incubated at 37
 
 
 
C in humidified
air for 2 h. At this cell density, soluble ligand concentration is relatively
unchanged over a 24-h period (Reddy et al., 1994). 3 ml mineral oil was
added to the dish to prevent evaporation, and the dish was then placed in
a heated stage insert for a Ludl 99S008 motorized stage on a ZEISS Axio-
vert 35 microscope. Cell boundaries and centroids were identified using
image processing software developed by Engineering Technology Center
running under a LabVIEW (National Instruments) and Concept Vi environ-
ment. 5–10 cells/field in 10 different fields were scanned every 10 min for
up to 6 h. The x and y coordinates of the cell centroids were recorded ev-
ery 10 min.
Figure 6. EGF released from autocrine 
cells does not stimulate migration of 
neighboring cells. WT HMECs were 
labeled with CellTracker green and cells 
expressing EGF-Ct were labeled with 
CellTracker orange. Cells were mixed 
overnight and followed for 4 h by two 
color fluorescence time-lapse microscopy 
using 4 min intervals. Shown are the 
initial images overlaid with trajectories 
marked at 40-min intervals. Left, cells 
in the absence of exogenous EGF.
Right, cells in the presence of 2 nM
exogenous EGF. 
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Cell mixing experiments
 
Cells were stained before mixing with CellTracker fluorescent dyes (Mo-
lecular Probes, Inc.). Cells expressing EGF-Ct were stained with Cell-
Tracker green CMFDA and parental cells were stained with CellTracker or-
ange CMTMR. The dyes were made as 10-mM stocks in DMSO and added
to cells at a final concentration of 5 
 
 
 
M in serum-free growth medium for
30 min at 37
 
 
 
C. Cells were rinsed for 30 min, removed with trypsin and
mixed at different ratios and densities, and cultured overnight in complete
medium. Plates were visually selected to yield 1:1 orange:green cells at a
low cell density. Fields of cells were recorded at 37
 
 
 
C on a heated stage for
4 h using both 488 and 562 nm excitation using a Nikon microscope auto-
mated with the Openlab software package (Improvision, Inc.). The migra-
tion speed and persistence of the cells was not altered by the staining pro-
tocol as compared with a parallel group of unstained cells.
 
Analysis of cell paths
 
Single cell speed was calculated by determining the total root mean
squares path length, as measured by the total centroid displacement, di-
vided by the tracking time (Dunn and Brown, 1987). The reported cell
speed 
 
  
 
SEM for each condition is an average 
 
 
 
200–250 cells. To calcu-
late the persistence time, the cell paths were fit to a persistent random walk
model. Average squared displacements were calculated for each cell using
a method of nonoverlapping intervals. The plot of average squared dis-
placements versus time for each cell was fit to the persistence random
walk model using the value of speed of cell calculated independently, to
obtain a value of persistence time of the particular cell. This value aver-
aged 
 
 
 
120–150 cells was reported as the persistence time 
 
 
 
 SEM at the
given conditions. Cell paths 
 
 
 
4 h long were not included in the calcula-
tion of persistence time but were included in the calculation of cell speeds.
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